Fujian Longsheng Biotechnology Co., Ltd. is a biopharmaceutical enterprise founded by Professor Wen Longping in 2014. The company's main business is the research and development, production, and sales of biological products that integrate transdermal short peptides, including pharmaceutical intermediates, topical drugs, and skincare cosmetics.

The core technology of the company is the "biological transdermal drug delivery technology based on transdermal short skin" invented by Professor Wen Longping's team, which can effectively carry protein drugs across the skin barrier. This technology was selected as one of the "Top Ten News in China's Basic Research" in 2006, and the research results were published in the international journal "Nature Biotechnology"